OPHTESIC 20 mg/g, eye gel in a single-dose container 20 tubes of 3.5 g, CIP 3400930250143
Active ingredients: Lidocaine hydrochloride, Lidocaine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Gel20 tubes of 3.5 g, CIP 3400930250143ophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OPHTESIC 20 mg/g, gel ophtalmique en récipient unidose
- Pharmaceutical form
- gel
- Route of administration
- ophtalmique
- Presentation description
- 20 tube(s) aluminium de 3,5 g
- Marketing authorisation holder
- LABORATOIRES DOLIAGE DEVELOPPEMENT
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 14 Feb 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- For professional use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61945454CIP73025014CIP133400930250143Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE LIDOCAÏNEgel | — | SA |
| CHLORHYDRATE DE LIDOCAÏNE ANHYDREgel | 20 mg · 1 g de gel | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.